Business strategy

Adapting our business model

Adapting our business model

Our approach to improving access to medicines

Our vaccines strategy

Our vaccines strategy

Christophe Weber on our tiered pricing vaccines strategy

Improving health through openness

Improving health through openness

A different approach to finding new medicines.

Our three strategic priorities are to grow a diversified global business, deliver products of value, and to simplify our operating model. But what does this mean for our research, our people, our products and our partners on a day-to-day basis? Find out in this section.